Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA vs. Amicar in Total Knee and Hip Arthroplasty
NCT02030821Phase 4Completed
- Sponsor
- Duke University
- Start
- Jan 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid and aminocaproic acid in hemorrhage, sponsored by Duke University. Primary endpoints: Total Blood Loss Over Course of Stay at 5 days and Number of Transfusions at 5 days. Started Jan 2015; status: completed.
02
Drugs
tranexamic acidaminocaproic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT02030821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030821.